- Home
- Publications
- Publication Search
- Publication Details
Title
Current opinion on bevacizumab on endometrial cancer treatment
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 15, Issue 2, Pages 299-307
Publisher
Informa Healthcare
Online
2014-12-24
DOI
10.1517/14712598.2015.995624
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
- (2014) B P Schneider et al. BRITISH JOURNAL OF CANCER
- Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms
- (2014) Sariah Liu et al. CANCER TREATMENT REVIEWS
- Bevacizumab Increases the Risk of Severe Congestive Heart Failure in Cancer Patients: An Up-to-Date Meta-Analysis with a Focus on Different Subgroups
- (2014) Wei-Xiang Qi et al. CLINICAL DRUG INVESTIGATION
- Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
- (2014) Robert A. Burger et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Risk of Cerebrovascular Events in Patients with Cancer Treated with Bevacizumab: A Meta-Analysis
- (2014) Pei-Yuan Zuo et al. PLoS One
- Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) N. Colombo et al. ANNALS OF ONCOLOGY
- A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer
- (2013) Akila N. Viswanathan et al. GYNECOLOGIC ONCOLOGY
- The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
- (2013) Limor Amit et al. PLoS One
- Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis
- (2013) Linda S. Elting et al. SUPPORTIVE CARE IN CANCER
- Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs
- (2012) Giuseppe Lombardi et al. ANTI-CANCER DRUGS
- Phase I Study of the Antiangiogenic Antibody Bevacizumab and the mTOR/Hypoxia-Inducible Factor Inhibitor Temsirolimus Combined with Liposomal Doxorubicin: Tolerance and Biological Activity
- (2012) J. Moroney et al. CLINICAL CANCER RESEARCH
- Bevacizumab in endometrial cancer treatment
- (2012) Matteo Morotti et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study
- (2012) Edwin A. Alvarez et al. GYNECOLOGIC ONCOLOGY
- Hypertension as a predictive biomarker in bevacizumab treatment for colorectal cancer patients
- (2012) Esther Tahover et al. MEDICAL ONCOLOGY
- Long-term remission of an advanced recurrent endometrial cancer in a heavily pretreated patient using a combined regimen with bevacizumab and metronomic cyclophosphamide
- (2011) Judith Reinhardt et al. ANTI-CANCER DRUGS
- Bevacizumab-Induced Hypertension
- (2011) Kostas N. Syrigos et al. BIODRUGS
- Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
- (2011) P Österlund et al. BRITISH JOURNAL OF CANCER
- An Algorithm for the Management of Hypertension in the Setting of Vascular Endothelial Growth Factor Signaling Inhibition
- (2011) M. Sitki Copur et al. Clinical Colorectal Cancer
- Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study
- (2011) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Venous Thromboembolic Events With Chemotherapy Plus Bevacizumab: A Pooled Analysis of Patients in Randomized Phase II and III Studies
- (2011) Herbert I. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials
- (2010) Vishal Ranpura et al. ACTA ONCOLOGICA
- Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A Meta-Analysis
- (2010) V. Ranpura et al. AMERICAN JOURNAL OF HYPERTENSION
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Bevacizumab Increases Risk for Severe Proteinuria in Cancer Patients
- (2010) S. Wu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab
- (2008) M. Scartozzi et al. ANNALS OF ONCOLOGY
- Targeting Angiogenesis Driven by Vascular Endothelial Growth Factors Using Antibody-Based Therapies
- (2008) Axel Grothey et al. CANCER JOURNAL
- Pathways Mediating Resistance to Vascular Endothelial Growth Factor-Targeted Therapy
- (2008) L. M. Ellis et al. CLINICAL CANCER RESEARCH
- Update on novel therapeutic agents for cervical cancer
- (2008) Josep Maria del Campo et al. GYNECOLOGIC ONCOLOGY
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search